DayQuil Super C
Allegations: Misleadingly marketing products as if they alleviate cold and flu symptoms when fine print on the side of the product packaging discloses that the products are “not intended to…
DayQuil Cough Medicine
Case Name (Date)
Diesel et al. v. The Procter & Gamble Co.
22-cv-892, E.D. Mo.
(July 2022)
Meza et al. v. The Procter & Gamble Co.
23-cv-91, C.D. Cal.
(Jan. 2023)
Product/Service
DayQuil cough medicine
Allegations
Falsely marketing medicine as “non-drowsy” when an ingredient (dextromethorphan hydrobromide, or DXM) causes drowsiness
Status
Pending
Class-Action Tracker
DayQuil Medicines with DXM
Allegations: Misleadingly marketing medicines as “non-drowsy” when an ingredient in them causes drowsiness
The Latest
Secret Clinical 72 HR Clear Gel
Excess product packaging collides with commitments to sustainability.
CATrends: Advertised Number of Loads on Liquid Laundry Detergents
Get a load of this.
Researchers Call on FDA (Again) to Remove ‘Ineffective’ OTC Cold and Flu Medicines
Products marketed to clear up stuffy noses and relieve sinus congestion don’t work, researchers say.
Companies Accused of Greenwashing
When companies green it, they better mean it.
CATrends: OTC Cold and Flu Medicines Falsely Marketed as ‘Non-Drowsy’
Several products marketed as ‘non-drowsy’ contain an ingredient that causes drowsiness, lawsuits claim.